Reapplix APS
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Aug 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jun 3, 2027The maintenance fee for Centrifuge and method of centrifuging a blood sample (US 10,493,467) comes due Jun 3, 2027. Unpaid by Dec 3, 2027, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 23, 2026
- Oct 27 US 12,773,427 Multilayered Blood Product
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 8 of 8
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,773,427 | Multilayered Blood Product In force · High confidence | In force | High confidence | |
| US 8,980,301 | Multilayered Blood Product In force · High confidence | In force | High confidence | |
| US 10,933,095 | Multilayered Blood Product In force · High confidence | In force | High confidence | |
| US 12,011,463 | Multilayered Blood Product In force · High confidence | In force | High confidence | |
| US 10,092,864 | Apparatus for preparing a multi-layered blood product by centrifugation In force · USPTO record | In force | USPTO record | |
| US 11,420,138 | Container for use when making a multi-layered blood product In force · USPTO record | In force | USPTO record | |
| US 10,493,467 | Centrifuge and method of centrifuging a blood sample In force · USPTO record | In force | USPTO record | |
| US 12,029,561 | Procoagulant factors suitable for subsequent autologous use In force · USPTO record | In force | USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 no status recorded
Showing 1 to 1 of 1, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. No title is shown: the bulk publication record carries none for these applications, and this site holds no USPTO file history for them.
| Application | Filed | Status |
|---|---|---|
| 18/678,399 | May 30, 2024 | No status recorded |